in this issue
EnviroTech :: Biotech
Lonza and Avalanche Biotechnologies Form Manufacturing Collaboration
12:08 AM MDT | May 16, 2012 | Deepti Ramesh
Lonza and Avalanche Biotechnologies (San Francisco, CA), a privately held biotechnology company, have formed a manufacturing collaboration focused on process development and scale-up efforts for the manufacturing of adeno-associated viral (AAV) vectors for gene therapy. Terms of the agreement were not disclosed. Avalanche Biotechnologies, which was founded in 2006, develops technologies and products for delivery of therapeutic proteins to the eye to treat wet age-related macular degeneration (AMD), as well as other ophthalmologic disorders. Avalanche...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee